• Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms 

      saini, kamal; de las Heras, Begona; Plummer, Ruth; Moreno, Victor; Romano, Marco; de Castro, Javier Mayor; Aftimos, Philippe; Fredriksson, Judy; Bhattacharyya, Gouri Shankar; Olivo, Martin Sebastian; Schiavon, Gaia; Punie, Kevin; Garcia-Foncillas, Jesus; Rogata, Ernesto; Pfeiffer, Richie; Orbegosa, Cecilia; Morrison, Kenneth; Curigliano, Giuseppe; Chin, Lynda; Saini, Monika Lamba; Rekdal, Øystein; Anderson, Steven; Cortes, Javier; Leone, Manuela; Dancey, Janet; Twelves, Chris; Awada, Ahmad (Journal article; Tidsskriftartikkel; Peer reviewed, 2020-09-08)
      The process of developing new anticancer therapeutics has been considered by some to be expensive, time consuming, bureaucratic, and, to some extent, inefficient. The coronavirus disease 2019 (COVID-19) pandemic has significantly affected clinical oncology studies and underlined the need to embrace and accelerate long-pending and awaited reforms to cancer clinical trial methodology.<p><p> This ...